Announcements Trials

Browse Landscape

Phase

Status

Completed 9 Active not recruiting 2 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 15 Rectal Neoplasms 4 Pancreatic Neoplasms 3 Colonic Neoplasms 3 Esophageal Squamous Cell Carcinoma 2 Cholangiocarcinoma 2 Biliary Tract Neoplasms 2 Stomach Neoplasms 1 Rhabdomyosarcoma 1 Rare Tumour 1 Pathologic Complete Response 1 Pancreatic Cancer Resectable 1 Neoplasms, Second Primary 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Medulloblastoma 1 Lung Neoplasms 1 Locally Advanced Low Rectal Adenocarcinoma 1 Esophageal Neoplasms 1 Cirrhosis, Familial, with Pulmonary Hypertension 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Neuroendocrine 1 CRC 1 Biliary Cancer Metastatic 1 Appendiceal Neoplasms 1 Advanced Malignant Neoplasm 1 Advanced Esophageal Carcinoma 1

Interventions

Temozolomide 2 fludarabine 1 Vascular Endothelial Growth Factor A 1 Triiodothyronine 1 Nivolumab 1 Irinotecan 1 Histocompatibility Testing 1 Etoposide 1 Cyclophosphamide 1 Blood Specimen Collection 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Medulloblastoma × Irinotecan × Clear all

NCT07346157 2026-06-01

PNOC044

University of California, San Francisco

Phase 1/2 Not yet recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡